I&L Biosystems Belgium

Leuven ·KBO/BCE: BE 0758.457.450

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	29-08-2025	29 d late	2025-00441881
31-12-2023	31-07-2024	22-07-2024	9 d early	2024-00270815
31-12-2022	31-07-2023	17-08-2023	17 d late	2023-00332486
31-12-2021	31-07-2022	25-07-2022	6 d early	2022-20217933

Metric	This company	Sector median	Position in the sector
Solvency	26.0%	27.2%	better than 48% of 970 sector peers
Net result	€11k	€23k	better than 42% of 970 sector peers
Equity	€120k	€170k	better than 45% of 970 sector peers
Gross operating margin	€248k	€173k	better than 58% of 968 sector peers
Staff costs	€234k	€166k	higher than 60% of 597 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€462k
Current assets	29/58	€462k
Amounts receivable within one year	40/41	€396k
Cash & bank	54/58	€65k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€462k
Equity	10/15	€120k
Contributions / capital	10/11	€25k
Accumulated profits (losses)	14	€95k
Amounts payable	17/49	€342k
Amounts payable within one year	42/48	€342k
Trade debts payable within one year	44	€109k
Income statement
Gross operating margin	9900	€248k
Operating result	9901	€14k
Financial income	75	€4k
Financial charges	65	€806
Result before taxes	9903	€17k
Income taxes	67/77	€6k
Net result for the period	9904	€11k
Result to be appropriated	9905	€11k

Summary

NACE primary	Groothandel in farmaceutische en medische artikelen(46460)
Legal form	Private limited company(610)
Incorporation	16-11-2020
Status	Active
Postal code	3000